Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 09, 2024 04:56 ET | Source: Research and Markets

Lutetium-177 Industry Research Report 2024: Carrier Added Lutetium-177, Non-Carrier-Added Lutetium-177 - Global Forecast 2024-2030

Dublin, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The "Lutetium-177 Market by Form (Carrier Added Lutetium-177, Non-Carrier-Added Lutetium-177), Route of Administration (Intravenous, Oral), End User,...
October 18, 2023 10:03 ET | Source: Research and Markets

Lutathera and Pepaxto Dominated the Peptide Drug Conjugates Market in 2022

Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Peptide Drug Conjugates Market Size, Share & Trends Analysis Report By Product (Lutetium, Melflufen, ANG1005, BT1718, CBX-12, Other Pipeline), By...
May 11, 2022 04:03 ET | Source: Research and Markets

Global Radioligand Therapy Markets, 2020-2021 & 2022-2031: Expanding Radiopharmaceutical Coverage & Radioligand Therapy Demand Inclined by Rising Prevalence of Cancer

Dublin, May 11, 2022 (GLOBE NEWSWIRE) -- The "Radioligand Therapy Market - A Global and Regional Analysis: Focus on Indication, Product, Biomarker, and Region - Analysis and Forecast, 2021-2031"...
April 23, 2019 09:00 ET | Source: Cancer Treatment Centers of America, Chicago

Cancer Treatment Centers of America Expands Neuroendocrine Tumor Clinical Program with Innovative Therapy for Rare Disease

Chicago, Ill., April 23, 2019 (GLOBE NEWSWIRE) -- Physicians at Cancer Treatment Centers of America® (CTCA) Chicago have a new option in the fight against rare neuroendocrine tumors (NETs) with the...